Ruolin Li

1.1k total citations
53 papers, 797 citations indexed

About

Ruolin Li is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Ruolin Li has authored 53 papers receiving a total of 797 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 14 papers in Molecular Biology and 8 papers in Cancer Research. Recurrent topics in Ruolin Li's work include DNA Repair Mechanisms (5 papers), Cancer Treatment and Pharmacology (5 papers) and Multiple Myeloma Research and Treatments (4 papers). Ruolin Li is often cited by papers focused on DNA Repair Mechanisms (5 papers), Cancer Treatment and Pharmacology (5 papers) and Multiple Myeloma Research and Treatments (4 papers). Ruolin Li collaborates with scholars based in China, United States and Australia. Ruolin Li's co-authors include Weijin Liu, Jia Liu, Hui Yang, Xue Qin, Qiliu Peng, Xianjun Lao, Shan Li, Hongjie Liang, Taijie Li and Zhiping Chen and has published in prestigious journals such as Physical Review Letters, PLoS ONE and Scientific Reports.

In The Last Decade

Ruolin Li

46 papers receiving 788 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruolin Li China 16 313 172 146 142 90 53 797
Shi Jin China 16 316 1.0× 117 0.7× 155 1.1× 99 0.7× 70 0.8× 52 825
Hongyang Zhao China 15 214 0.7× 120 0.7× 133 0.9× 84 0.6× 106 1.2× 35 702
Bin Xie China 20 600 1.9× 157 0.9× 218 1.5× 211 1.5× 37 0.4× 46 1.3k
Yee‐Jee Jan Taiwan 21 511 1.6× 97 0.6× 106 0.7× 183 1.3× 59 0.7× 58 964
Wei Qiu China 17 222 0.7× 250 1.5× 101 0.7× 217 1.5× 126 1.4× 54 717
Dae Hyun Song South Korea 19 465 1.5× 129 0.8× 195 1.3× 193 1.4× 37 0.4× 90 1.1k

Countries citing papers authored by Ruolin Li

Since Specialization
Citations

This map shows the geographic impact of Ruolin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruolin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruolin Li more than expected).

Fields of papers citing papers by Ruolin Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruolin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruolin Li. The network helps show where Ruolin Li may publish in the future.

Co-authorship network of co-authors of Ruolin Li

This figure shows the co-authorship network connecting the top 25 collaborators of Ruolin Li. A scholar is included among the top collaborators of Ruolin Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruolin Li. Ruolin Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
4.
Li, Ruolin, Yu Liu, Ailing Yang, et al.. (2024). Profiles of chemotherapy-induced peripheral neuropathy in breast cancer patients undergoing taxane-based chemotherapy: A latent class analysis. European Journal of Oncology Nursing. 74. 102758–102758.
6.
Liu, Yu, et al.. (2022). Effectiveness of Nonpharmacologic Interventions for Chemotherapy-Related Cognitive Impairment in Breast Cancer Patients. Cancer Nursing. 46(5). E305–E319. 13 indexed citations
9.
Peng, Qiliu, Lu Yu, Xianjun Lao, et al.. (2014). Association between OGG1 Ser326Cys and APEX1 Asp148Glu polymorphisms and breast cancer risk: a meta-analysis. Diagnostic Pathology. 9(1). 108–108. 17 indexed citations
10.
Liang, Hongjie, Taijie Li, Meng Li, et al.. (2014). The MMP-1, MMP-2, and MMP-9 gene polymorphisms and susceptibility to bladder cancer: a meta-analysis. Tumor Biology. 35(4). 3047–3052. 36 indexed citations
11.
Peng, Qiliu, Shan Li, Xianjun Lao, et al.. (2014). Interleukin-12B +1188A/C polymorphism contributes to increased hepatocellular carcinoma susceptibility: Evidence from a meta-analysis. Clinics and Research in Hepatology and Gastroenterology. 38(6). 735–743. 4 indexed citations
12.
Deng, Yan, Meng Li, Jian Wang, et al.. (2014). Susceptibility to hepatocellular carcinoma in the Chinese population—associations with interleukin-6 receptor polymorphism. Tumor Biology. 35(7). 6383–6388. 9 indexed citations
13.
Peng, Qiliu, Zhiping Chen, Lu Yu, et al.. (2014). Current evidences on XPC polymorphisms and gastric cancer susceptibility: a meta-analysis. Diagnostic Pathology. 9(1). 96–96. 11 indexed citations
14.
Peng, Qiliu, Xianjun Lao, Weizhong Tang, et al.. (2014). CASP8 -652 6N Del Polymorphism Contributes to Colorectal Cancer Susceptibility: Evidence from a Meta-Analysis. PLoS ONE. 9(2). e87925–e87925. 6 indexed citations
15.
Peng, Qiliu, Shi Yang, Xianjun Lao, et al.. (2014). Association of Single Nucleotide Polymorphisms in VDR and DBP Genes with HBV-Related Hepatocellular Carcinoma Risk in a Chinese Population. PLoS ONE. 9(12). e116026–e116026. 51 indexed citations
16.
Liang, Hongjie, Li Xie, Yu He, et al.. (2013). Association of MDR1 G2677T polymorphism and leukemia risk: evidence from a meta-analysis. Tumor Biology. 35(3). 2191–2197. 10 indexed citations
17.
Yan, Yulan, Hongjie Liang, Ruolin Li, et al.. (2013). XRCC3 Thr241Met polymorphism and ovarian cancer risk: a meta-analysis. Tumor Biology. 35(3). 2711–2715. 13 indexed citations
18.
Peng, Qiliu, Cuiju Mo, Weizhong Tang, et al.. (2013). DNA repair gene XRCC3 polymorphisms and bladder cancer risk: a meta-analysis. Tumor Biology. 35(3). 1933–1944. 14 indexed citations
19.
Liang, Hongjie, Zhiming Liu, Xu Chen, et al.. (2013). Association of XRCC3 Thr241Met Polymorphisms and Gliomas Risk: Evidence from a Meta-analysis. Asian Pacific Journal of Cancer Prevention. 14(7). 4243–4247. 19 indexed citations
20.
Zeng, Zhiyu, Yanqiong Liu, Zhiming Liu, et al.. (2013). CYP2D6 polymorphisms influence tamoxifen treatment outcomes in breast cancer patients: a meta-analysis. Cancer Chemotherapy and Pharmacology. 72(2). 287–303. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026